M&A Deal Summary

Magnum Capital Industrial Partners Acquires Probelte

On November 28, 2021, private equity firm Magnum Capital Industrial Partners acquired chemicals company Probelte

Acquisition Highlights
  • This is Magnum Capital Industrial Partners’ 2nd transaction in the Chemicals sector.
  • This is Magnum Capital Industrial Partners’ 17th transaction in Spain.

M&A Deal Summary

Date 2021-11-28
Target Probelte
Sector Chemicals
Buyer(s) Magnum Capital Industrial Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Probelte

Murcia, Spain
Probelte is a manufacturer and distributor of health solutions for the agricultural industry. Probelte produces and distributes a comprehensive portfolio of solutions for agricultural applications providing crop nutrition and protection through biological and synthetic ingredients. Probelte was founded in 1970 and is based in Murcia, Spain.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Magnum Capital Industrial Partners

Madrid, Spain

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2006
PE ASSETS 1.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Magnum Capital is a private equity firm focused on investing in upper middle-market companies located in Spain and Portugal. Magnum prefers control investments in the industrial and service sectors. The Firm's target investment size is €30 to €100 million in businesses valued from €150 to €800 million. Prospective investment situations include family-owned companies with potential for 'increased operating efficiencies', corporate spin-offs, shareholder liquidity needs, and Iberian companies looking to expand beyond the local area. Magnum Capital was formed in 2006 and has offices in Madrid and Lisbon.


DEAL STATS #
Overall 21 of 24
Sector: Chemicals M&A 2 of 2
Type: Buyout (LBO, MBO, MBI) M&A Deals 13 of 15
Country: Spain M&A 17 of 20
Year: 2021 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-01 Apices

Madrid, Spain

Apices is a Clinical Research Organization (CRO) that supports clinical sponsors (pharmas/clinical investigators) in the execution of clinical trials. Apices is based in Madrid, Spain.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-01 Indiba

Barcelona, Spain

Indiba is a design and manufacturing of non-invasive medical equipment based on radiofrequency technology. Indiba was founded in 1983 and is based in Barcelona, Spain.

Sell -